Spyre Therapeutics, Inc.SYRENASDAQ
LOADING
|||
Net Income Contraction
Trending higher, below historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-208.02M
↓ 117% below average
Average (9y)
$-96.01M
Historical baseline
Range
High:$-11.29M
Low:$-338.79M
CAGR
+38.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-208.02M | +38.6% |
| 2023 | $-338.79M | -304.2% |
| 2022 | $-83.81M | -27.4% |
| 2021 | $-65.80M | +18.7% |
| 2020 | $-80.89M | -3.4% |
| 2019 | $-78.25M | -76.5% |
| 2018 | $-44.35M | -62.8% |
| 2017 | $-27.24M | -25.5% |
| 2016 | $-21.70M | -92.1% |
| 2015 | $-11.29M | - |